Medivir AB (Medivir AB) Days Sales Outstanding : 106.67 (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Medivir AB Days Sales Outstanding?

Medivir AB's average Accounts Receivable for the three months ended in Dec. 2023 was $0.51 Mil. Medivir AB's Revenue for the three months ended in Dec. 2023 was $0.43 Mil. Hence, Medivir AB's Days Sales Outstanding for the three months ended in Dec. 2023 was 106.67.

The historical rank and industry rank for Medivir AB's Days Sales Outstanding or its related term are showing as below:

MVRBF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 0.21 Med: 7.39 Max: 272.53
Current: 272.53

During the past 13 years, Medivir AB's highest Days Sales Outstanding was 272.53. The lowest was 0.21. And the median was 7.39.

MVRBF's Days Sales Outstanding is ranked worse than
86.52% of 890 companies
in the Biotechnology industry
Industry Median: 71.92 vs MVRBF: 272.53

Medivir AB's Days Sales Outstanding declined from Dec. 2022 (199.76) to Dec. 2023 (106.67).

Medivir AB Days Sales Outstanding Historical Data

The historical data trend for Medivir AB's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medivir AB Days Sales Outstanding Chart

Medivir AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

4.93

0.98

0.26

Medivir AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															199.76	1,123.82	274.24	731.90	106.67

Competitive Comparison of Medivir AB's Days Sales Outstanding

For the Biotechnology subindustry, Medivir AB's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medivir AB's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medivir AB's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Medivir AB's Days Sales Outstanding falls into.

Medivir AB Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Medivir AB's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0.744	*	365
=	0					/	0.744	*	365
=	0.00

Medivir AB's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.505	+	0)	/	1 )	/	0.432	*	365 / 4
=	0.505					/	0.432	*	365 / 4
=	106.67

Medivir AB (OTCPK:MVRBF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Medivir AB Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Medivir AB's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Medivir AB (Medivir AB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medivir AB (OTCPK:MVRBF) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

MVIR:Sweden MVR0:Germany

Address

Lunastigen 5, PO Box 1086, 2nd floor, Huddinge, SWE, 141 22

Website

https://www.medivir.com

Medivir AB develops drugs with a focus on cancers where there are medical needs. The company invests in indication areas where available treatment methods are limited or lacking and there are opportunities to offer significant improvements to patients. Medivir focuses on the development of MIV-818, a prodrug that has been designed to provide a targeted anti-tumor effect in the liver while minimizing any side effects. Birinapant, a SMAC mimetic, has been out-licensed for development in combination with IGM antibodies for the treatment of solid tumors.